Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Everolimus (RAD001): Optimizing mTOR Inhibition for Cancer A
2026-05-03
Everolimus (RAD001) empowers cancer researchers with a robust, quantifiable means to inhibit mTOR and dissect PI3K/Akt pathway dynamics in both in vitro and in vivo settings. This guide translates rigorous bench findings and workflow enhancements into actionable steps for maximizing assay fidelity and troubleshooting bottlenecks.
-
Shufeng Xingbi Therapy Restores Immune and Microbial Balance
2026-05-02
This study evaluates Shufeng Xingbi Therapy's (SFXBT) effect on immune regulation and intestinal flora in a rat model of allergic rhinitis. The findings reveal that SFXBT significantly alleviates nasal inflammation by rebalancing Th1/Th2 immunity and beneficially modulating gut microbiota—offering mechanistic insight for integrated immunomodulation strategies.
-
Epidermal Growth Factor: Optimizing Recombinant Human EGF Wo
2026-05-01
Unlock the full potential of recombinant human EGF in advanced cell culture and stemness assays. This guide details stepwise protocols, troubleshooting strategies, and the latest evidence-driven innovations that empower high-throughput, reproducible research.
-
Stiripentol as an LDH Inhibitor: Novel Insights into Immunom
2026-05-01
Explore how Stiripentol, a potent LDH inhibitor, uniquely disrupts lactate metabolism to advance both epilepsy research and tumor immunometabolism studies. This in-depth review unveils mechanisms, reference-driven insights, and experimental guidance beyond existing resources.
-
Phosbind Biotin: Dinuclear Metal Complex for Phosphorylation
2026-04-30
Phos binding reagent (Phosbind) Biotin empowers sequence-independent, high-sensitivity detection of phosphorylated proteins in Western Blots, streamlining signal transduction research. Its dinuclear metal complex enables robust workflows where traditional antibodies fall short, as shown in cutting-edge plant stress biology.
-
EZ Cap™ Cy5 EGFP mRNA (5-moUTP): Dissecting Dual Fluorescenc
2026-04-30
Explore how EZ Cap™ Cy5 EGFP mRNA (5-moUTP) advances real-time mRNA delivery and translation efficiency assays with precise dual-fluorescence quantitation. This article provides a mechanistic deep dive and practical guidance, differentiating from prior content by focusing on quantitative assay development and direct application of recent scientific advances.
-
Sulfaphenazole Rapidly Restores Perfusion in Pressure Injury
2026-04-29
This study demonstrates that sulfaphenazole, a potent CYP 2C6/2C9 inhibitor, reduces the severity of thermal and pressure injuries in mice by rapidly restoring tissue perfusion and minimizing ischemia–reperfusion (I/R) damage. The findings provide mechanistic insight and translational relevance for therapies targeting vascular dysfunction and wound healing.
-
Enhanced ECL Chemiluminescent Substrate Detection Kit: Appli
2026-04-29
Unlock ultra-sensitive, low-background western blot detection with the Enhanced ECL Chemiluminescent Substrate Detection Kit from APExBIO. This guide bridges cutting-edge neuroinflammation research to practical assay optimization, advanced troubleshooting, and workflow upgrades for robust protein immunodetection.
-
NSC 87877: Precision Shp2 Inhibition for Advanced Assay Desi
2026-04-28
Explore how NSC 87877, a selective Shp2 inhibitor, enables advanced experimental design in neuroinflammation, cancer, and pain research. Uncover unique assay strategies and actionable insights not found in standard guides.
-
Tacalcitol-Induced NGF Expression in Human Epidermal Keratin
2026-04-28
This article reviews the foundational study demonstrating that Tacalcitol, a synthetic analog of vitamin D3, transcriptionally induces nerve growth factor (NGF) production in human epidermal keratinocytes. The findings provide a mechanistic rationale for exploring vitamin D3 analogs in peripheral neuropathy and dermatological research.
-
Live-Dead Cell Staining Kit: Dual-Fluorescent Viability Assa
2026-04-27
The Live-Dead Cell Staining Kit enables precise discrimination of live and dead cells in cultured cell populations using Calcein-AM and Propidium Iodide dual staining. This product is best suited for researchers needing reliable live/dead quantification in fluorescence microscopy, flow cytometry, or cytotoxicity assays, but is not intended for diagnostic or clinical applications.
-
KR-12 Peptide Engineering: Advanced Strategies Against Drug-
2026-04-27
The reference review details the structural engineering of KR-12, a minimal human cathelicidin-derived antimicrobial peptide, and its potential to overcome key challenges in targeting antibiotic-resistant bacteria and biofilms. Innovations include origami-inspired design, nano-formulation for targeted delivery, and immobilization on biomaterials, offering promising translational directions for precision antimicrobial therapies.
-
Reserpine (N1867): Practical Guidance for Laboratory Researc
2026-04-26
Reserpine (SKU N1867) addresses the need for a high-purity, well-characterized standard in neurotransmitter depletion and antihypertensive mechanism research. It is best suited for workflow-controlled experimental setups where reliable depletion of monoamines is essential. Direct application in diagnostic or clinical settings is not supported and should be avoided.
-
Lactate-GPR81/FARP1 Signaling Enables Insulin-Independent Gl
2026-04-25
This study uncovers a lactate-activated GPR81/FARP1 signaling axis that drives insulin-independent glucose uptake in skeletal muscle. By elucidating this mechanism, the research provides novel insight into exercise-induced glycemic control and highlights GPR81 as a promising therapeutic target for metabolic diseases.
-
Enhancing Assay Reliability with Nadolol (SQ-11725): Practic
2026-04-24
This article guides biomedical researchers and lab technicians through real-world assay challenges where Nadolol (SQ-11725) (SKU BA5097) delivers data-driven solutions. Leveraging scenario-based Q&A, it demonstrates how validated sourcing and protocol optimization with Nadolol elevate reproducibility and sensitivity in cardiovascular and related cell-based models.